Equity Distribution for ESPERION THERAPEUTICS Inc
Ticker | ESPR |
FIGI | BBG004KB3S72 |
CUSIP | 29664W105 |
Sector | Healthcare |
Equity Type | Common Stock |
No. Companies Holding this Equity | 166 / 2.4% |
Percentage held by institutional investors | 100.0% |
About
Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia